News
EU approval for J&J’s single-shot COVID-19 vaccine
The European Commission has granted a conditional marketing authorisation for Johnson & Johnson’s (J&J) single-dose COVID-19 vaccine in individuals aged 18 years and older.
You're using an outdated browser. To get the most out of this website, as well as many others, please consider upgrading to a modern browser, such as Google Chrome, Mozilla Firefox, or Microsoft Edge.
The European Commission has granted a conditional marketing authorisation for Johnson & Johnson’s (J&J) single-dose COVID-19 vaccine in individuals aged 18 years and older.